Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Cancer Outcomes
100%
HPV16
100%
Human Papillomavirus Genotypes
100%
Overall Survival
57%
Phylogenic
57%
Event-free Survival
42%
Multivariate Analysis
28%
Genotype
28%
Implications for Treatment
14%
Viral
14%
High Risk
14%
Tumor
14%
Curative Intent
14%
Patient Outcomes
14%
High-risk Human Papillomavirus (HR-HPV)
14%
Single Institution
14%
Univariate Analysis
14%
Survival Disparities
14%
Comorbidity Index
14%
Favorable Prognosis
14%
Human Papillomavirus Negative
14%
Non-white
14%
Clinical Profile
14%
Stage IV Disease
14%
High Age
14%
HIV+ Patients
14%
T4 Tumor
14%
7th Edition
14%
T4 Stage
14%
Treatment De-intensification
14%
Pharmacology, Toxicology and Pharmaceutical Science
Oropharynx Cancer
100%
Human Papillomavirus Type 16
100%
Human Papillomavirus
100%
Oropharynx Carcinoma
100%
Overall Survival
57%
Event Free Survival
42%
Diseases
42%
Neoplasm
28%
HIV
14%
Cohort Study
14%
Comorbidity
14%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Cladistics
100%
Wart Virus
100%
Human Papillomavirus Type 16
87%
Overall Survival
50%
Oropharynx
50%
Event Free Survival
37%
Multivariate Analysis
25%
Human Immunodeficiency Virus
12%
Cohort Study
12%
Comorbidity
12%
Immunology and Microbiology
Wart Virus
100%
Cladistics
100%
Human Papillomavirus Type 16
87%
Overall Survival
50%
Oropharynx
50%
Event Free Survival
37%
Human Immunodeficiency Virus
12%
Comorbidity
12%
Agricultural and Biological Sciences
Genotyping
100%
Cladistics
100%
Papillomaviridae
100%
Oropharynx
50%
Multivariate Analysis
25%
Human Immunodeficiency Virus
12%
Endpoints
12%